Pap test pioneers stake out growth opportunities
This article was originally published in Clinica
Executive Summary
Cytyc, the market leader in the new generation of Pap tests, reported strong results in the third quarter, while its much smaller rival, TriPath Imaging, admitted that it had over-estimated its likely sales for 2004. However, TriPath is finding room for expansion in markets that are dominated by Cytyc, and the latter has had to look beyond disposable test and instrument revenues for its future growth strategy.